Literature DB >> 15550178

What is the treatment of choice for Tl squamous cell carcinoma of the larynx?

Alfio Ferlito, Patrick J Bradley, Alessandra Rinaldo.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15550178     DOI： 10.1258/0022215042450760

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN： 0022-2151            Impact factor:   1.469


× No keyword cloud information.
  5 in total

1.  Cost-minimisation and cost-effectiveness analysis comparing transoral CO₂ laser cordectomy, laryngofissure cordectomy and radiotherapy for the treatment of T1-2, N0, M0 glottic carcinoma.

Authors:  Pedro Diaz-de-Cerio; Julian Preciado; Francisco Santaolalla; Ana Sanchez-Del-Rey
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-08       Impact factor: 2.503

Review 2.  Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alfio Ferlito; Carlos Suárez; Jochen A Werner; Eric M Genden; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

Review 3.  Primary treatment of the anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alessandra Rinaldo; Carlos Suárez; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Snehal G Patel; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

Review 4.  Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification.

Authors:  G Almadori; F Bussu; G Paludettii
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

5.  Study of the Histopathologic Characteristics and Surface Morphologies of Glottic Carcinomas With Anterior Vocal Commissure Involvement.

Authors:  Jianhui Wu; Jing Zhao; Zhangfeng Wang; Zenghong Li; Jie Luo; Bing Liao; Zhiyun Yang; Qihong Liu; Bin Wang; Weiping Wen; Wenbin Lei
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.